Use of octreotide in the management of severe duodenal bleeding after unrelated-donor bone marrow transplantation

Int J Hematol. 2003 Aug;78(2):176-7. doi: 10.1007/BF02983391.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Bone Marrow Transplantation*
  • Duodenal Diseases / drug therapy
  • Duodenal Diseases / etiology
  • Female
  • Gastrointestinal Agents / administration & dosage*
  • Gastrointestinal Hemorrhage / drug therapy*
  • Gastrointestinal Hemorrhage / etiology
  • Graft vs Host Disease / complications
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Octreotide / administration & dosage*
  • Tissue Donors

Substances

  • Gastrointestinal Agents
  • Octreotide